Reducing Site Burden for Oncology Trials

One of the key focus areas of Merck’s Global Trial Optimization (GTO) initiative is to reduce the burden on the research sites with which they partner. Sites have historically been tasked with tracking and reporting on the status of candidates over long and complicated trials with suboptimal, manual, and often duplicative tools. It’s a dynamic that can lead to lengthy trial delays, especially in oncology where protocols are complex and the demands on candidates are heavy. In this webinar, you’ll learn how the GTO team at Merck is using data and technology to reduce site burden related to oncology trial enrollment and visit management so that research staff can focus on their work with patients.